Introduction
============

Since the report of Hayflick and Moorehad in 1961 that normal human fibroblasts have only a limited capacity for proliferation in culture [@B1], many types of normal somatic cell cultures from humans, rodents, birds and other species have been shown to exhibit a finite capacity for cell division. Most normal somatic cells *in vivo* also cannot divide indefinitely [@B2]. Hayflick noted that most tumor cells can proliferate without limitation, and proposed that replicative senescence of normal cells might also contribute to organismal ageing [@B1]. Replicative senescence is the progressive decline in the ability to proliferate, which is an intrinsic property of most normal somatic cells. *In vivo*, replicative senescence is limited to cells that have the ability to divide, but does not apply to postmitotic cells such as mature muscle and neurons. During replicative senescence, cells sense the number of division they have run, not chronological time [@B2].

According to the telomere hypothesis for replicative senescence, the telomere length acts as a mitotic clock for sensing the number of division, and telomere shortening leads to senescence and subsequent death [@B3]. The telomere is a special structure at the chromosome ends to prevent them from end-to-end fusion or being recognized as DNA damage [@B4]. In vertebrates, telomeres consist of tandem repeats of TTAGGG [@B5] and telomere-associated proteins [@B6]. As a result of an inherent inability of DNA polymerase to replicate the 5\' ends of linear chromosomes, cell division leads to progressive telomeric shortening to a critical length that is proposed to act as a trigger for cell growth arrest and cellular senescence [@B3]. Immortal cells such as totipotent stem cells and tumor cells can proliferate without an apparent limitation, because these cells possess telomerase activity that overcomes telomeric attrition by adding telomeric repeats to the chromosome ends and thus prevent cells from replicative senescence [@B7].

Expression of telomerase activity has been examined in diverse organisms. In unicellular eukaryotes, cell division corresponds to asexual reproduction, and telomerase is constitutively expressed to maintain telomeres from generation to generation. In multicellular organisms, telomerase studies have focused on mammals that grow only in the embryonic and juvenile stages but not in the adult and scenescent stages. In these organisms, the need of distinct cells and tissues are decoupled from the requirement for organismal reproduction. This is most evident in humans: telomerase activity in normal adult somatic tissues is limited to stem cells with high proliferation potential, but is found in the germline and cancer cells [@B8]. Primary human cells senesced, whereas their transgenic counterparts ectopically expressing telomerase became immortalized and extended their life-span (Bodnar et al., 1998). In fact, forced telomerase expression has since been widely used for cell immortalization [@B9],[@B10]. In contrast, telomerase activity has been detected ubiquitously in all somatic adult tissues of lower vertebrate such the rainbow trout [@B11] and invertebrates such as lobster [@B12], where the growth is indeterminate, and age is proportional to size. In the zebrafish showing functional ageing and very gradual senescence, telomerase activity has been found throughout embryogenesis and in adult muscles [@B13].

Telomerase is a ribonucleoprotein complex consisting of two subunits: the catalytic subunit [te]{.ul}lomerase [r]{.ul}everse [t]{.ul}ranscriptase (TERT) that adds telomeric repeats to elongate telomere, and the telomerase RNA (TR) subunit that contains a template region complementary to the telomeric sequence for reverse transcription [@B14]. In human, TERT is the primary regulator for enzyme activity as its expression correlates with telomerase activity [@B15], whereas TR is ubiquitously expressed in all tissues irrespective of telomerase activity [@B16]. This notion is supported by the fact that telomerase activity can be restored upon ectopic Tert expression [@B17]. Therefore, the analysis of *tert* RNA expression and the direct determination of telomerase activity by telomeric repeat amplification protocol (TRAP) are often used as reliable measure of telomerase expression. Recent studies have revealed that Tert possesses telomerase activity-independent functions to attain cancer stem cell characteristics in glioma cells by inducing EGFR expression [@B18] and to protect ATM-deficient hematopoietic stem cells from ROS-induced apoptosis [@B19].

The *tert* cDNA has been isolated from yeast [@B20] and tetrapod vertebrates including frog [@B21], chicken [@B22], mouse [@B23], hamster [@B24], dog [@B25] and human [@B26]. Vertebrate Tert proteins share several motifs in three regions. The N-terminal region contains four evolutionarily conserved vertebrate motifs (v1 to v4), followed by a telomerase specific T-motif [@B21]. The central region contains seven well-conserved reverse transcriptase (RT) motifs (1, 2, A, B, C, D and E) that define the catalytic region and display sequence similarity to other RTs [@B27]. Specifically, motifs 1, 2 and A correspond to the finger domain of other RTs, whereas motifs B-E corresponds to the core catalytic domain. The C-terminus harbors three conserved motifs (v5 to v7) essential for telomerase activity [@B28].

Telomerase activity and expression exhibit salient differences in diverse animals. In general, ubiquitous telomerase expression has been documented in lower vertebrates and invertebrates, in contrast to preferential or specific expression in proliferating human cells such as stem cells and cancer cells. The role of telomerase in cell growth, differentiation and embryonic development remains to be elucidated in non-mammalian animals. The teleost fish medaka (*Oryzias latipes)*is an excellent model for vertebrate development [@B29]. This fish has ease for maintenance under laboratory conditions, easy embryology, a short generation time of ten weeks, a short life span of three years, many inbred or mutant strains, powerful experimental tools such as embryo microinjection for gene knockdown [@B30] or chimeric assay [@B31]. Importantly, medaka has embryonic stem (ES) cells [@B32],[@B33], adult spermatogonia capable of test-tube sperm production [@B34] and even haploid ES cells [@B35]. The medaka genome draft sequence is available (<http://dolphin.lab.nig.ac.jp/medaka>). These features make medaka a suitable model for telomerase biology *in vivo* and *in vitro*.

This study was aimed at the examination of medaka *tert* expression and roles in ES cells and early embryonic development. We show that the medaka *tert* locus can produce multiple variants besides the standard *terta* encoding the longest isoform TertA, the homolog of the mammalian Tert protein. Furthermore, we reveal that *terta* RNA expression and telomerase activity are ubiquitous *in vivo* and *in vitro*, whereas other *tert* variants exhibit differential expression *in vivo* and *in vitro*during ES cell differentiation. Therefore, the multiple *tert* variants have differential expression during cell differentiation.

Materials and Methods
=====================

Fish
----

This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Advisory Committee for Laboratory Animal Research in Singapore and approved by this committee (Permit Number: 27/09). Medaka of orange-red variety, South Korean population (SOK), albino strains i^1^ and i^3^ were maintained as described [@B36]. Embryos were maintained at 26\~28°C and staged as described [@B37]. Unless otherwise indicated, chemicals were purchased from Sigma, enzymes and PCR reagents were from Promega.

Cell culture
------------

Medaka cell cultures were grown at 28°C under ambient air. Three stem cell lines and four new cell cultures were used in this study. MES1 [@B32] and HX1 [@B35] are medaka diploid and haploid ES cell lines and were maintained for undifferentiated growth or induced differentiation via embryoid body (EB) formation as described. SG3 is a medaka spermatogonial stem cell line derived from the adult testis and was maintained as described [@B34]. Besides the three stem cell lines, we established four new cell lines that appear to consist of differentiated cells. These are S125, Sok, Or1 and i^1^, which were derived from blastula embryos of SOK and the adult testes of SOK, orange-red variety and *i^1^* medaka, respectively. Cell cultures from blastula embryos were derived according to [@B32] and testicular cultures according to [@B34]. Cells were subcultured at a 1:3 splitting ratio. All the seven cell lines used in this study had undergone ≥50 passages and thus ≥100 doublings.

Gene identification and isolation
---------------------------------

When we started this work, there was no fish *tert* sequence available. In order to isolate a medaka *tert* gene by using the homology cloning approach, the chicken Tert was used as a query for a blast search against a medaka genome draft sequence (<http://dolphin.lab.nig.ac.jp/medaka/>). This led to the identification of scaffold 3719 which predicts partial sequence of a putative Tert. On a sequence alignment of this predicted amino acid (aa) sequence with other known vertebrate Tert proteins generated several highly conserved domains. The genomic sequences encoding these domains were used to design primers TF and TR (Table [1](#T1){ref-type="table"}) for isolating a partial cDNA by reverse transcriptase-polymerase chain reaction (RT-PCR). Total RNA was extracted from medaka blastula embryos of by using the TRIzol reagent (Invitrogen, Carlsbad, CA).

First-strand cDNA (5\' and 3\'-RACE-Ready) was generated from \~ 1-μg of total RNA in a 10-μl volume by using the SMART^TM^ RACE cDNA amplification Kit (Clontech, Mountain View, CA). RT-PCR was run in 25 μl of 1 X PCR buffer containing 2 mM MgCl~2~, 0.2 μM of each primer, 200 μM dNTPs each, 50-200 ng cDNA template and 1 U *Taq*DNA polymerase for 35 cycles (94°C 30 s, 60°C 30 s and 72°C 3 min 10 sec at 94ºC, 10 sec at 53ºC, and 3 min at 72ºC for 35 cycles, followed by 10 min at 72ºC with *Taq* DNA polymerase (Invitrogen). The PCR product was separated on 1% agarose gels, documented using a UV transilluminator coupled with a CCD camera (Advanced American Biotechnology, Fullerton, CA) and recovered by using UltraClean^TM^ 15 DNA Purification Kit (MO BIO Laboratories, Carlsbad, CA). After TA-cloning into pGEM-T easy vector (Promega, Madison, WI), plasmid DNA was prepared by using the DNA Purification Kit (iNtRON Biotechnology, Kyunki-Do, Korea), and the inserts were sequenced by using the BigDye Terminator v3.1 Cycle Sequencing Kit on ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA). Eight clones were found to contain an identical insert of 3,003 nt for a partial but continuous open reading frame.

The partial cDNA was extended to its full length by RACEs. For 5\' RACE, a 5\' RACE-Ready cDNA and two nested gene specific primers (5TR and 5TRn) were used, while 3\'RACE was run by using a 3\' RACE-Ready cDNA and two nested gene primers (3TF and TFn). Hot-start PCR was run for 12 cycles at 94ºC for 10 sec, Ta (annealing temperature, decreasing from 74ºC at a rate of 1ºC per cycle) for 10 sec and 72ºC for 1 min, followed by 25 cycles of 10 sec at 94ºC, 10 sec at 68ºC, and 1 min at 72ºC. A fragment of 503 bp and 199 bp was obtained from 5\' and 3\'RACE reaction, respectively. The PCR products were similarly cloned and sequence. The full-length cDNA was assembled and PCR-cloned from the 5\'-RACE-Ready cDNA template by using terminal primers fTF (AAAATGACATCCGGGGATTTGTCGAGCG) and fTR (CCGCTCAGATCACATCTGCATAGCCAGGAAGTCCAG).

Sequence analysis
-----------------

The PCR products were cloned into pGEM-T vector. The inserts were sequenced in both directions on the Applied Biosystems 3130xl (Applied Biosystems, MA). BLAST searches were run against public databases by using BLASTN for nucleotide sequences and BLASTP for protein sequences. Multiple sequence alignment was conducted by using the Vector NTI suite 8. Phylogenetic trees were constructed by using the DNAMAN package (<http://www.lynnon.com/>).

RNA isolation and RT-PCR analysis
---------------------------------

Total RNA samples were extracted from medaka embryos at different developmental stages, adult tissues (brain, heart, liver, ovary, testis, skin, intestine), and cell lines of ES cells (MES1; Hong et al, 1996), spermatogonial cells (SG3; Hong et al., 2004b), and serial cultures of adult testis-derived, uncharacterized cell types (Liu T & YH, unpublished). The synthesis of cDNA from 1-2 μg of total RNA was primed by oligo dT~18~ by using the Molony murine leukemia virus reverse transcriptase (Promega, Madison, WI). RT-PCR was run for 30 cycles (β-actin) and 35 cycles (*tert*) for 10 sec at 94ºC, 10 sec at 60ºC and 50 sec at 72ºC by using cDNA-specific primers listed in Table [1](#T1){ref-type="table"}. Specifically, fTF and fTR flanking the full-length cDNA sequence were used for cDNA cloning, and RTF (spanning exon 11 and 12) and RTR (spanning exon 15 and 16) were used for RT-PCR analysis.

Telomerase activity assay
-------------------------

Telomerase activity was examined by the sensitive telomeric repeat amplification protocol (TRAP) (Eisenhauer et al., 1997) by using the TRApeze^®^ Telomerase Detection Kit (Chemicon \#S7700, Temecula, CA). For this, 20-50 embryos or 40-100 mg tissues were washed with phosphate buffered saline (PBS) and homogenized in 200 μl of ice-cold CHAPS lysis buffer containing 200 units/ml RNasin^®^ ribonuclease inhibitor (Promega, Madison, WI). Crude protein samples were quantified by using the Bio-Rad protein assay reagent (Bio-Rad, Foster City, CA). Aliquots of 500 ng protein (cell or tissue extract) or from an equal number of embryos was assayed for telomerase activity in a 25-μl volume containing 20 mM Tris-HCl (pH 8.3), 1.5 mM MgCl~2~, 63 mM KCl, 0.005% Tween-20, 1 mM EGTA, 50 μM of dNTPs each, and 0.1 μg of primer TS (AATCCGTCGAGCAGAGTT). After 30 min incubation at 30ºC, the reaction was stopped by heating at 94ºC for 3 min. Following addition of 0.1 μg of primer RP (CCCTTACCCTTACCCTTACCCTAA) and 1 unit of *Taq* DNA polymerase, the telomerase reaction products were PCR-amplified for 33 cycles (10 sec at 94ºC, 10 sec at 55ºC, and 30 sec at 72ºC). The PCR products were resolved on 0.75-mm thick, 12.5% denaturing polyacrylamide gels at 200 V for 1.5 h. The gels were stained for 15-20 min in 1 μg/ml SYBR Green I Nucleic Acid Stain (Cambrex, East Rutherford, NJ) and documented on a gel imaging system (Synoptics, Cambridge). Negative controls were similarly run except that protein samples were inactivated by heating for 15 min at 90ºC before addition to the reaction mixture.

Microscopy and Photography
--------------------------

Observation and imaging on Leica MZFIII stereo microscope with Nikon E4500 digital camera (Nikon Corp), Zeiss Axiovertinvert 2 invert microscope and Axiovert 200 upright microscope with a Nikon E4500 digital camera or a Zeiss AxioCam M5Rc digital camera (Zeiss Corp., Germany) were described previously [@B35].

RESULTS
=======

Medaka *tert* cDNA and its encoded Tert protein
-----------------------------------------------

We obtained a total five RNA variants designated *terta* to *terte*. The *terta* is 3511 nt and was obtained from a blastula cDNA library. It encodes the longest isoform TertA with 1,090 amino acid residues (aa), a putative polyadenylation signal upstream of a poly A tail of 27 nt, a 5\' untranslated region (UTR) of 101 nt and a 3\' UTR of 137 nt (Fig. [1](#F1){ref-type="fig"}). On a sequence alignment, the medaka TertA shows all structural motifs/domains previously identified in several vertebrate Tert proteins. These are the N-terminal motifs v1-v4 and T, the central RT-motifs 1, 2, A-E, and C-terminal essential motifs v5-v7, which are present in the corresponding regions (Fig. [2](#F2){ref-type="fig"}).

The predicted medaka TertA shows a 34% maximal identity to the human TERT protein (Fig. [3](#F3){ref-type="fig"}A). On a phylogenetic tree (Fig. [3](#F3){ref-type="fig"}B), the medaka TertA together with Tert proteins from four other fish species forms a cluster, while Tert proteins from tetrapod vertebrates forms another cluster, conforming to their organism relationships. Besides a common domain structure, the medaka TertA shares similarities with known vertebrate Tert sequences in predicted molecular mass (123 kDa) and isoelectric point (pI = 10.5) (Fig. [3](#F3){ref-type="fig"}A).

This cDNA was obtained as illustrated in Fig. [3](#F3){ref-type="fig"}A. A search on a medaka genome draft sequence database identified scaffold 3719 encoding aa sequences with significant homology to the known vertebrate Tert proteins. Three steps of RT-PCR in combination of 5\'- and 3\'-RACEs from a blastula cDNA library resulted in the composition of the full length cDNA. The continuity of the assembled cDNA was confirmed by sequencing the cloned RT-PCR products obtained by using a pair of terminal primers.

Medaka *tert* gene and chromosomal location
-------------------------------------------

A comparison between the medaka *tert* cDNA and genomic sequence on scaffold 3719 led to the elucidation of its genomic organization. The medaka *tert* locus consists of 16 exons (Fig. [4](#F4){ref-type="fig"}A), as in the mouse (ENSMUSG00000021611) and human *tert* gene (ENSG00000164362). A blast search by using the medaka cDNA as query against the medaka genome sequence led to the location the medaka *tert* gene as the locus OlPS67_ORYLA on chromosome 11 (<http://www.ensembl.org/index.html>). Our medaka *tert* cDNA clone is 99% and 98% identical to the chromosomal locus at nt and aa levels, respectively. Convincingly, the medaka *tert* gene shows a chromosomal synteny to the human gene (Fig. [3](#F3){ref-type="fig"}C). Taken together, the medaka *tert* encodes an ortholog of the human TERT by sequence, gene structure and chromosome synteny.

Multiple Tert isoforms are the products of alternative splicing
---------------------------------------------------------------

RT-PCR analysis by using the terminal primer pair led to the identification of 5 variants from the *tert* locus. Variant *tertb* was derived from the adult testis, whereas variants *tertc* to *terte* were from the embryo. Comparisons between cDNAs and the genomic sequence established that these variants were the products of alternative splicing (Figure [4](#F4){ref-type="fig"}A). Specifically, *tertb* results from the exclusion of exons 2\~6, *tertc* and *tertd* arise from the inclusion of both introns 4\~5 and only intron 5, respectively, whereas *terte* is due to the exclusion of exon 5, respectively (Figure [4](#F4){ref-type="fig"}A). In *tertb*, the open reading frame is maintained, leading to isoform TertB of 444 aa, which lacks the region spanning the linker to the central RT motif A (Figure [4](#F4){ref-type="fig"}B); the variants *tertc* to *terte* acquire premature stop codons by frame shifting, predicting isoforms TertC, D and E of 619 aa, 690 aa and 665 aa in length, respectively, which all have an incomplete RT and lack the C-terminal region (Figure [4](#F4){ref-type="fig"}B). Therefore, all the isoforms TertB\~E would act as mutant forms of TertA or functions independently of telomerase activity.

Medaka *tert* RNA Expression
----------------------------

It has been well documented that telomerase activity is mainly regulated at the transcriptional level, and that *tert* expression is largely associated with telomerase activity. A salient difference has been reported for *tert* gene expression: differential expression in human and ubiquitous expression in *Xenopus*. It has been reported that hTert mRNA is differentially expressed in cancers, stem cells and other telomerase positive cells [@B26]. The medaka *tert* transcript was found to be present in all adult somatic tissues examined (Figure [5](#F5){ref-type="fig"}A), including the brain and heart that are thought to consist largely of postmitotic cells. During embryogenesis, the *tert* is abundant from the 2-cell stage up to the blastula stage, gradually reduced to a low level at hatch (Figure [5](#F5){ref-type="fig"}B). Since zygotic transcription takes place after the midblastula transition at the blastula stage, the *tert* transcript may be inherited at a high level as maternal message, in accordance with its abundance in the adult ovary (Figure [5](#F5){ref-type="fig"}A).

Previously, we have derived three medaka ES cell lines [@B32]. MES1, one of the three lines, has been shown to be pluripotent, because it is competent for chimera formation [@B33], induced and directed differentiation [@B32],[@B38]. We have also established SG3, a normal adult spermatogonial stem cell line capable of sperm production *in vitro*[@B34]. As expected, both stem cell lines highly express the *tert* transcript (Figure [5](#F5){ref-type="fig"}C). Interestingly, a similarly high level of the *tert* was also detected in an adult testis-derived cell culture (Sok; Figure [5](#F5){ref-type="fig"}C).

In contrast, *tertb* exhibited tissue- and stage-specific expression. In adult tissues, *tertb* was restricted to the adult testis; in developing embryos, *tertb* was absent before gastrulation; in cell lines, *tertb* was barely detectable (Figure [5](#F5){ref-type="fig"}A-C). Therefore, *terta,* but not *tertb,* is ubiquitously expressed *in vivo* and *in vitro*.

Expression of telomerase activity
---------------------------------

If the *terta* transcription is the major regulation of telomerase, the ubiquitous *terta* expression RNA would indicate a universal expression of telomerase activity in the medaka. To address this issue, we performed TRAP assays, a standard for measuring cellular telomerase activity. Telomerase activity is present in adult tissues (Fig. [5](#F5){ref-type="fig"}D), developing embryos (Figure [5](#F5){ref-type="fig"}E) and cell cultures (Figure [5](#F5){ref-type="fig"}F). Heat-inactivation of the tissue or cell extracts abolished the formation of TRAP products. These results demonstrate that telomerase activity, like the ubiquitous *terta* transcript, is also ubiquitous *in vivo* and *in vitro*.

Notably, seven medaka cell lines were used for examining *tert* expression and/or telomerase activity (Figure [5](#F5){ref-type="fig"}F). These cell lines represent five different medaka strains and populations (Table [2](#T2){ref-type="table"}) and have different phenotypes (Figure [5](#F5){ref-type="fig"}G-J). Taken together, there is a positive correlation between telomerase activity and *terta* expression, and ubiquitous *terta* expression and/or telomerase activity *in vitro* appears to be independent of strains and cellular phenotypes of stable cell cultures.

Up-regulation of *tertc* expression upon differentiation *in vitro* and *in vivo*
---------------------------------------------------------------------------------

In human, telomerase expression delineates with cellular immortality *in vivo* and *in vitro*, and is widely used for monitoring undifferentiated stem cells in culture. We wanted to determine whether *tert* expression would be also indicative of an undifferentiated state of medaka stem cells in culture. To this end, we made use of diploid ES cell line MES1 and haploid ES line HX1, which have been show to expression a set of seven pluripotency genes including nanog and oct4 under undifferentiated culture condition but dramatically reduce or lost their expression upon induced differentiation[@B35],[@B39]. We observed that *terta* expression remained easily detectable in both ES cell lines before and after differentiation. However, *tertc* expression was absent in undifferentiated ES cells but become evident upon their differentiation (Figure [6](#F6){ref-type="fig"}A). Successful induction of ES cell differentiation was demonstrated by the down-regulation of *nanog* expression and the up-regulation of *no tail* expression (Figure [6](#F6){ref-type="fig"}A). *nanog* and *no tail* are the markers for pluripotency and differentiation of medaka ES cells, respectively[@B39]. Interestingly, expression of *tertc* and *tertd* was barely detectable in early developing embryos until 6 h post fertilization (hpf) when cell differentiation has not yet started, but commenced until 12 hpf and increased further until 24 hpf (Figure [6](#F6){ref-type="fig"}B). Therefore, unlike mammals in which *tert* expression or telomerase activity is a stem cell marker[@B40], the lack of expression of truncated RNA variants such as *tertc* but not *terta* expression is associated with pluripotency of undifferentiated ES cells and developing embryos in medaka.

Taken together, the medaka *tert* produces multiple variants by alternative splicing, which exhibit different expression patterns. On the basis of RNA expression pattern and protein structure, the isoform TertA appears to be the functional homolog of the mammalian Tert, whereas all the isoforms TertB\~E may be the dominant-negative mutants and/or possess additional functions independent on the RT activity. Consequently, it appears that in medaka, telomerase expression and activity may be controlled at both the post-transcriptional and post-translational levels. Apparently, the expression of transcript variants for truncated Tert isoforms appears to be a marker of ES cell differentiation.

DISCUSSION
==========

The present study reports the isolation and expression of the medaka *tert* gene. Four lines of evidence demonstrate that medaka *tert* encodes an ortholog of the known Tert proteins. First, the medaka Tert predicted from variant *terta* is similar to its mammalian homologs in the number of aa, molecular weight and isoelectric point. Second, the medaka Tert shows a maximal sequence identity to previously identified Tert proteins, and displays all conserved motifs characteristic of tetrapod Tert proteins. Third, the medaka *tert* share a common genomic organization with mammalian genes. Finally, the medaka *tert* shows a chromosomal syntenic relationship with the human gene.

The ability to produce multiple different protein products via differential promoter usage and/or alternative splicing is a hallmark of many eukaryotic genes. In the case of *tert* gene, seven, three and two isoforms are available in annotated human, chimpanzee and chicken genomes (<http://www.ensembl.org/index.html>), respectively, which are products of RNA variants that share the first exon. In this study, PCR cloning by using primers flanking the full length open reading frame of the *terta* leads to a total of five RNA variants, four of which are alternatively splicing products by inclusion of intron 4 and/or 5 and exclusion of exon 5 and are thus encode novel isoforms, as similar isoforms have not yet been reported in other organisms. Because of large deletion (TertB) or significant truncation (TertC\~E), the four medaka isoforms TertB to TertE should lack the Tert activity and perhaps function independently of telomerase activity. In mammals, Tert has recently demonstrated to function through a telomere independent mechanism to control stem cell pluripotency and survival [@B18],[@B19].

In this study, we have made several important observations on medaka telomerase expression. Notably, *tert* expression and telomerase activity are both ubiquitous *in vivo* during embryonic and adult life, which conforms to ubiquitous *tert* expression and/or telomerase activity previously reported in invertebrates [@B41] and lower vertebrates including fish species such as rainbow trout (*Oncorhynchus mykiss*)[@B11], marine medaka (*Oryzias melastigma*) [@B42] and more importantly, the medaka [@B43]. These animals grow continuously throughout life, possess a high capability for regeneration and have little senescence even beyond adulthood. Consequently, telomerase expression occurs in many cells, irrespective of individual age and differentiation status, to support a high proliferation capacity for growth and regeneration. The medaka situation is in sharp contrast to the mammalian situation where telomerase expression is closely associated with immortal cells such as stem cells and cancer cells [@B7]. Humans and other mammals show active growth in embryonic and juvenile phases and no growth in adult and senescent phases. During their long adult life period, size and weight are kept essentially constant. Therefore, the differential telomerase expression between mammals and non-mammalian animals accompanies differences in cell proliferation and organismal growth.

We have utilized a total of seven cell lines to telomerase expression *in vitro*. Interestingly, three stem cell lines and four non-stem cell lines show a comparably high level of *terta* expression and/or telomerase activity. Therefore, *terta* expression in stable cell lines is also ubiquitous, irrespective of cell origin and phenotype. This observation has an important implication. All the seven medaka cell lines used in this study had undergone ≥50 passages at a 1:3 and thus ≥100 doublings, which indicates the immortality or continuous proliferation capacity. In accordance with the known primary function of telomerase activity for cellular immortality, it is not surprising that non-stem cell cultures also exhibit a high level of *tert* expression to support active division *in vitro*, similar to the situation of stem cell cultures. Hence, ubiquitous *terta* expression *in vitro*in stable cell lines underscores the role of telomerase in cell growth.

It deserves to note that the medaka *tert* variants exhibit differential expression. Interestingly, variant *terta* maintains ubiquitous expression *in vivo* and *in vitro*, other variants display tissue- and stage-specific expression (*tertb*) or differentiation-specific expression (*tertc*). Therefore, *terta* expression and the lack of expression of truncated *tert* variants are indicative of an undifferentiated state of stem cells in culture. This is contrast to the mammalian situation, where a high level of *tert* expression is a stem cell marker [@B40]. In this regard, the medaka *tert* is unique, because it is not its differential transcription but its differential alternative splicing at the post-transcription level that reflects differentiation of ES cells. It has been well-documented that the RNA expression of many pluripotency genes is high in undifferentiated ES cells but dramatically reduced upon ES cell differentiation [@B35],[@B39].

Stem cell lines have a prominent difference from non-stem cell lines in that stem cells possess pluripotency, namely the potential for differentiation. Our work does not distinguish whether expression of *tert* variants for truncated isoforms is associated with differentiation per se and/or comprised proliferation, because ES cells upon differentiation exhibit reduced proliferation. Telomerase functions primarily in regulating telomeric length to count the number of cell divisions, and overt replicative senescence due to the absence of telomerase activity appears gradually after \~50 cell cycles in human fibroblast culture [@B1]. Induced ES differentiation occurs rapidly over a short period of 5\~10 days, during which cells could undergo 3\~6 cycles of division [@B32],[@B35]. It is likely that expression of *tert* variants for truncated isoforms is associated with ES cell differentiation in culture. Future work will determine whether the expression of truncated *tert* variants is the cause or consequence of stem cell differentiation.

Our findings that the *tert* can produces multiple isoforms with differential expression in differentiation make medaka a model organism to study the Tert functions *in vitro* and *in vivo*.
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![**Medaka *tert* sequence.**Top, Nucleotide sequence of medaka *terta*. Bottom, Deduced amino acid sequence of medaka TertA. Sequences of different exons are shown alternatively in black and blue color. ATG, TGA and a putative polyadenylation signal are shown in bold. Primer sequences used for RT-PCR analyses are underlined. Sequences absent in *tertb* and TertB are highlighted in grey.](ijbsv07p0426g01){#F1}

![**Tert sequence alignment.** Conserved motifs are boxed. Ol, *Oryzias latipes* (medaka); Fr, *Takifugu rubripes* (pufferfish); Xl, *Xenopus laevis*(clawed frog); Mm, *Mus musculus* (mouse); Hs, *Homo sapiens* (human). For accession numbers see Figure [3](#F3){ref-type="fig"}.](ijbsv07p0426g02){#F2}

![**Tert protein, gene structure and chromosome context.**(A) Phylogenetic tree. The bootstrap value is 100 at all branches. Sequence accession numbers follow organisms. (B) Domain structure of Tert proteins and cloning steps. The N-terminal, central and C-terminal regions are defined. Four conserved vertebrate motifs (v1-v4) and the telomerase-specific motif (T) in the N-terminal region, seven reverse transcriptase motifs (1, 2, A, B, C, D and E) in the central region, and three conserved motifs (v5-v7) in the C-terminal region are boxed. Sizes of cDNAs and proteins, predicted molecular weights and isoelectric point (pI) are shown in boxes. The difference in protein size is due mainly to the variable N-terminal region, in particular the linker between motifs v1 and v2. Note the medaka protein is the smallest among vertebrate proteins so far reported. Cloning steps are illustrated above the medaka Tert protein. Positions of primers used for cloning are indicated, their sequences are listed in Table [1](#T1){ref-type="table"}. (C) Comparison of *tert* gene structure between medaka and human. The primary *tert* transcript is 4 times larger in human than in medaka. The human introns are not proportional. (D) Chromosome synteny between medaka and human. Chromosomal locations are shown in parentheses.](ijbsv07p0426g03){#F3}

![**RNA variants and protein isoforms.** (A) Genomic organization. Filled box, translated exon; open box, untranslated exon; thin line between boxes, intron. Exons are numbered within boxes, and sizes of introns are given between boxes. Asterisks denote stop codons. Arrows depict PCR primers. (B) Medaka isoforms TertA to TertE. Different domains are highlighted in different colors as for their encoding exons shown in (A). Sequences have been deposited in the Genbank under accession numbers DQ248968 (TertA) and JF326825-JF326828 (TertB-E).](ijbsv07p0426g04){#F4}

![**RNA expression and telomerase activity. (A-C)** *tert* RNA expression in adult tissues (A), developing embryos (B) and cell cultures (C). Numbers of PCR cycles are indicated. MES1, medaka ES cells; SG3, adult medaka spermatogonial stem cells; Or1 and Sok, uncharacterized cell cultures from the adult medaka testis; neg, negative control by using total RNA instead of cDNA as a template. An equal amount of cDNA reaction was used for each sample. β-actin was used as a loading control. (D-F) Telomerase activity in adult tissues (D), developing embryos (E) and cell cultures (F). Positive (pos; +) and negative controls (neg; -) were TRAP reactions by using the commercially supplied extract without and with heat inactivation. S125 and i1, uncharacterized cell cultures from medaka embryos of strain SOK and adult medaka testis of strain i^1^. (G-J) Phenotypes of representative cell lines. Scale bars, 50 μm.](ijbsv07p0426g05){#F5}

![**RNA expression of tert variants during differentiation *in vitro* and *in vivo*.** (A) RNA expression during ES cell differentiation. Notably, expression of variant *tertc* increases upon ES cell differentiation. (B) RNA expression in representative stages of embryos and adult tissues. Elevated expression of variant *tertc* and *tertd* is seen in embryos at 12 h and 24 h post fertilization when overt cell commitment and differentiation take place. *nanog* and *ntl* (*no tail*) were used as markers of pluripoteny and differentiation, respectively. *β-actin* was used as a loading control. Arrows define PCR primers as illustrated in Figure [4](#F4){ref-type="fig"}A.](ijbsv07p0426g06){#F6}

###### 

Primers used for medaka *tert* cloning and PCR analysis\*

  Gene (accession)               Primer                                     Sequence                   Ta (ºC)
  ------------------------------ ------------------------------------------ -------------------------- ---------
  Tert (DQ248968.1)              TF                                         AAAAGGAGGAGAAATGTTTTGGCC   55
  TR                             TCACATCTGCATAGCCAGGAAGTCCAG                                           
  3TF                            AGCGCCGGTTGGAGAGGCTTCTGGGAG                70                         
  3TFn                           CTGCTGGACTTCCTGGCTATGCAGATGTGA                                        
  5TR                            CAGGTAGCGGGTGACGTCTGTGCCGAG                72                         
  5TRn                           AGCGGAAGTGGTCTGCATCCCGGTCCTCCT                                        
  fTF                            TCCTTGAATCACCCATACTGC                      54                         
  fTR                            TTCCATTTTCTTTTCTTTTAATCACTTTAAC                                       
  vTF                            cgccc**AAGCTT**ATGACATCCGGGGATTTGTCGAGCG   60                         
  vTR                            cgcgg**ACTAGT**CATCTGCATAGCCAGGAAGTCCAGC                              
  RTF                            CAAAGACTATTCCAGCTATGCAGGCCTCTC             60                         
  RTR                            CCAACCGGCGCTTCCATTTGTGCAGG                                            
                                 tertb-RTF                                  cgagctgtaatcaggtggatttc    59
                                 tertb-RTR                                  cactgacggtacgtcttctttc     
  nanog (NP_001153902)           Forward                                    CTCCACATGTCCCCCCTTATC      60
  Reverse                        AGGATAGAATAGTCACATCAC                                                 
  oct4 (AY639946)                Forward                                    GCTTTCTTTGGCGTAAACTCGTC    60
  Reverse                        TCATCCTGTCAGGTGACCTACC                                                
  no tail (ENSORLG00000011262)   Forward                                    ATGAGCGCGTCGAACCCGGAC      60
  Reverse                        AGACGGGCGCTTTCATCCAGT                                                 
  β-actin (D89627)               Forward                                    TGGGATGACATGGAGAAGATCTG    56
  Reverse                        TGGGAATTCCAATCCAGACAGAGTATT                                           

\* Irrelevant sequences are in small letter, and introduced restriction sites are in bold. Ta, annealing temperature

###### 

Cell lines and their origin

  Cell line   Origin                    Strain       Phenotype        Reference
  ----------- ------------------------- ------------ ---------------- ------------
  MES1        Fertilization blastulae   HB32C        ES cell          [@B32]
  SG3         Adult testis              i^3^         Germ stem cell   [@B34]
  HX1         Gynogenetic blastulae     i^1^         ES cell          [@B35]
  S125        Fertilization blastulae   SOK          Unknown          This study
  Sok         Adult testis              SOK          Unknown          This study
  Or1         Adult testis              Orange-red   Unknown          This study
  i1          Adult testis              i^1^         Unknown          This study
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